Form 8-K - Current report:
SEC Accession No. 0001213900-17-011474
Filing Date
2017-11-07
Accepted
2017-11-07 08:00:33
Documents
2
Period of Report
2017-11-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k110717_citiuspharma.htm 8-K 13873
2 PRESS RELEASE f8k110717ex99-1_citiuspharma.htm EX-99.1 8583
  Complete submission text file 0001213900-17-011474.txt   23744
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38174 | Film No.: 171181148
SIC: 2834 Pharmaceutical Preparations